Skip to content

Efficacy and safety of dexmedetomidine on improving baroreflex sensitivity in elderly patients with hypertension under epidural anesthesia: a randomized controlled trial.

The effect of dexmedetomidine on baroreflex sensitivity in elderly patients with hypertension under epidural anesthesia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033679
Enrollment
Unknown
Registered
2020-06-08
Start date
2020-06-15
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

DEX?:Dexmedetomidine 0.5 µg/kg was administered within 10min followed by infusion at 0.4 µg/kg/h
MID?:Midazolam 2mg was administered within 10min followed by infusion of saline
C?:Equal volume of saline was administered

Sponsors

Taizhou Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 65 years with a clear history of hypertension; 2. The patients to be operated on under the spinal epidural anesthesia; 3. Patients with ASA grade II-III; 4. The subjects understood and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with systolic blood pressure >= 180mmhg and / or diastolic blood pressure >= 110mmhg; 2. Patients with history of secondary hypertension and diabetes; 3. Patients with sinus bradycardia, poor atrioventricular conduction, or allergic to the study drug were found by ECG; 4. Patients with hyperthyroidism and other diseases that may affect heart function; 5. Patients with history of central nervous system diseases; 6. Patients with a history of serious cardiopulmonary diseases, such as cardiomyopathy, cor pulmonale, etc; 7. Patients with vascular or skin diseases who are unable to measure upper limb blood pressure 8. Patients with severe liver and kidney dysfunction (liver enzyme > 3 times the upper limit of normal or estimated glomerular filtration rate < 30ml / min); 9. Subjects who ingested caffeine or alcohol within 24 hours; 10. Subjects who have participated in or are participating in other clinical studies within three months.

Design outcomes

Primary

MeasureTime frame
baroreflex sensitivity;

Secondary

MeasureTime frame
Systolic blood pressure;diastolic blood pressure;mean arterial pressure;pulse oxygen saturation;heart rate;

Countries

China

Contacts

Public ContactXiaodan Wang

Department of Anesthesiology, Taizhou Hospital, Zhejiang Province

wangxd8905@enzemed.com+86 15958663558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026